Biocept, Inc. (BIOC:NASDAQ) rocketted at $1.34, a gain of 59.4%. On Fri, Sep 08, 2023, BIOC:NASDAQ hit a New 2-Week High of $1.34. The stock got featured on our News Catalysts scanner on Fri, Sep 08, 2023 at 01:31 PM in the 'BIOTECH' category. From Fri, Aug 25, 2023, the stock recorded 55.56% Up Days and 30.00% Green Days
The stock spiked on Fri, Sep 08, 2023 at $1.85 with a volume of 102M+.
About Biocept, Inc. (BIOC:NASDAQ)
Biocept Inc is an early commercial-stage molecular oncology diagnostics company. It develops and commercializes proprietary circulating tumor cell and circulating tumor DNA assays utilizing a standard blood sample.
Top 10 Gainers:
- Axcella Health Inc. (AXLA:NASDAQ), 70.67%
- Signature Bank (SBNY:NASDAQ), 63.33%
- Vinco Ventures Inc. (BBIG:NASDAQ), 62.7%
- Biocept, Inc. (BIOC:NASDAQ), 59.45%
- Evolving Systems, Inc. (EVOL:NASDAQ), 33.93%
- Oncorus Inc. (ONCR:NASDAQ), 32.35%
- Lantronix, Inc. (LTRX:NASDAQ), 28.25%
- Golden Heaven Group Holdings Ltd. (GDHG:NASDAQ), 27.56%
- Societal CDMO Inc. (SCTL:NASDAQ), 26.68%
- EZGO Technologies Ltd. (EZGO:NASDAQ), 23.76%